MDxHealth SA Stock Euronext Bruxelles
Stocks
MDXH
BE0974461940
Biotechnology & Medical Research
| Market Cap | 18.98M 21.72M 17.51M 16.14M 30.43M 2.09B 31.1M 209M 82.33M 1.02B 81.56M 79.77M 3.53B | P/E 2026 * |
-0.65x | P/E 2027 * | -0.94x |
|---|---|---|---|---|---|
| Enterprise Value | 141M 161M 130M 120M 226M 15.53B 231M 1.55B 611M 7.61B 606M 592M 26.19B | EV / Sales 2026 * |
1.47x | EV / Sales 2027 * | 1.47x |
| Free-Float |
88.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MDxHealth SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 18/02/2019 | |
Ron Kalfus
DFI | Director of Finance/CFO | 52 | 22/07/2019 |
Miriam Reyes
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 75 | 29/09/2021 |
Eric Bednarski
BRD | Director/Board Member | 54 | 30/07/2020 |
Hilde Windels
BRD | Director/Board Member | 61 | 01/11/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -2.58% | - | - | 21.72M | |
| +3.90% | -0.39% | +376.72% | +599.59% | 39.58B | |
| -1.70% | +4.46% | +7.46% | +57.67% | 34.69B | |
| -2.01% | -0.76% | +26.35% | -6.83% | 34.42B | |
| +0.06% | +0.34% | +2.32% | +29.30% | 27.11B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +68.48% | +117.39% | 15.36B | |
| +1.12% | +1.91% | +15.90% | +19.65% | 14.05B | |
| 0.00% | +1.36% | +15.74% | -30.62% | 13.02B | |
| -0.08% | -3.01% | +1,271.69% | +649.69% | 11.76B | |
| Average | +0.17% | +0.04% | +223.08% | +179.48% | 22.91B | |
| Weighted average by Cap. | +0.24% | +0.36% | +171.43% | +187.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 95.89M 110M 88.49M 81.56M 154M 10.57B 157M 1.06B 416M 5.18B 412M 403M 17.82B | 108M 123M 99.56M 91.77M 173M 11.89B 177M 1.19B 468M 5.82B 464M 453M 20.05B |
| Net income | -28M -32.03M -25.83M -23.81M -44.88M -3.08B -45.88M -309M -121M -1.51B -120M -118M -5.2B | -17.95M -20.54M -16.56M -15.27M -28.78M -1.98B -29.41M -198M -77.87M -969M -77.13M -75.44M -3.33B |
| Net Debt | 122M 140M 113M 104M 196M 13.44B 200M 1.35B 529M 6.58B 524M 513M 22.66B | 140M 160M 129M 119M 225M 15.44B 230M 1.55B 608M 7.56B 602M 589M 26.03B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
